|
FAM102B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.30500005141232E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.42570000249975E-08 |
| Normal-vs-Stage2 |
2.879100E-03 |
| Normal-vs-Stage3 |
2.60480000002783E-06 |
| Normal-vs-Stage4 |
1.69910000002993E-06 |
| Stage1-vs-Stage2 |
7.620000E-01 |
| Stage1-vs-Stage3 |
5.898200E-01 |
| Stage1-vs-Stage4 |
9.058600E-01 |
| Stage2-vs-Stage3 |
9.956400E-01 |
| Stage2-vs-Stage4 |
7.336200E-01 |
| Stage3-vs-Stage4 |
6.219200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.3995999872476E-10 |
| Normal-vs-AfricanAmerican |
4.646400E-02 |
| Normal-vs-Asian |
5.917100E-03 |
| Caucasian-vs-AfricanAmerican |
5.457100E-03 |
| Caucasian-vs-Asian |
6.541200E-01 |
| AfricanAmerican-vs-Asian |
1.110620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.02959996084451E-09 |
| Normal-vs-Female |
4.97610000005366E-06 |
| Male-vs-Female |
1.141610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.781960E-02 |
| Normal-vs-Age(41-60Yrs) |
1.24499999198946E-09 |
| Normal-vs-Age(61-80Yrs) |
5.27720000031984E-07 |
| Normal-vs-Age(81-100Yrs) |
5.680000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.318200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.297800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.878800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.777590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.006230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.376000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.061800E-03 |
| Normal-vs-Grade 2 |
7.76359976306651E-10 |
| Normal-vs-Grade 3 |
2.85759999996138E-07 |
| Normal-vs-Grade 4 |
4.10010000000405E-05 |
| Grade 1-vs-Grade 2 |
9.350000E-01 |
| Grade 1-vs-Grade 3 |
4.994200E-01 |
| Grade 1-vs-Grade 4 |
7.047400E-01 |
| Grade 2-vs-Grade 3 |
5.327800E-02 |
| Grade 2-vs-Grade 4 |
3.528400E-01 |
| Grade 3-vs-Grade 4 |
7.119600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.30909999401996E-09 |
| Normal-vs-ccB subtype |
3.35500000003819E-07 |
| ccA subtype-vs-ccB subtype |
3.649200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.99289998024244E-09 |
| Normal-vs-N1 |
3.974100E-02 |
| N0-vs-N1 |
7.290000E-01 |
|
|
